Autres langues bioAffinity Technologies, Inc.

Actions

BIAF

US09076W1099

Temps Différé Nasdaq Autres places de cotation 19:29:02 29/04/2024			Varia. 5j.	Varia. 1 janv.
2,535 ^USD	+6,96%		-15,50%	+72,39%

01/04	BioAffinity Technologies, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
08/03	BioAffinity Technologies clôture une offre d'actions de 2,5 millions de dollars	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth	24/04
BioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening	09/04
BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
BioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results	01/04
BioAffinity Technologies, Inc. announced that it has received $2.624 million in funding	20/03
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	11/03
BioAffinity Technologies Closes $2.5 Million Equity Offerings	08/03
Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement	08/03
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	08/03
WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement	06/03
BioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	06/03
BioAffinity Technologies Reports Accelerating Sales Growth of CyPath Lung	06/03
BioAffinity Technologies, Inc. announced that it expects to receive $2.624 million in funding	06/03
BioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung	05/03
BioAffinity Technologies News Update	21/02
Medical Director of Pennsylvania's Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies Medical and Scientific Advisory Board and Incorporates CyPath Lung into Medical Practice	07/02
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice	06/02
BioAffinity Technologies, Inc. Appoints Sandeep Bansal to Medical and Scientific Advisory Board	06/02
BioAffinity Technologies In The News	30/01
BioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer	23/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues bioAffinity Technologies, Inc.

Actions

BIAF

US09076W1099

Autres langues

Filtres